Table 2. Gender, age, and tumor location distribution of cases used in KRAS and BRAF mutation analysis.
Characteristics | KRAS mutation analysis | BRAF mutation analysis | |||||||
---|---|---|---|---|---|---|---|---|---|
n | mut+ | % | p-value | n | mut+ | % | p-value | ||
Gender | Male | 106 | 48 | 45.3 | 0.448a | 58 | 4 | 6.9 | 1.000a |
Female | 72 | 37 | 51.4 | 35 | 2 | 5.7 | |||
Age | ≤70 | 149 | 66 | 44.3 | 0.036b | 83 | 6 | 7.3 | 1.000a |
>70 | 29 | 19 | 65.5 | 10 | 0 | 0.0 | |||
Tumor location | Colorectal tissues | 146 | 65 | 44.5 | 0.065b | 81 | 5 | 6.2 | 0.574a |
Metastatic tissues | 32 | 20 | 62.5 | 12 | 1 | 8.3 |
aFisher’s exact test
bChi-squared test